SOMA-1
Pre-clinical- Indications
- Cancer, Neurological disorders
Company intelligence / Profile preview
Opto Biosystems
Cambridge, England, United Kingdomopto.bio ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Opto Biosystems has developed a minimally invasive implantable neural interface platform ("SOMA‑1") designed to extract high-fidelity electrical information from the body. The technology leverages machine learning to derive patient-specific neural biomarkers for disease state assessment and treatment efficacy. The company’s initial focus targets hard-to-treat cancers by providing new diagnostic insights through real-time monitoring of electric fields within tissues. No clinical results have been published as of May 2025; the company remains in preclinical R&D stages.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Implantable neurotechnology devices (neural interfaces, sensors)Electrical stimulation and recording devicesWireless injectable biological interfaces
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Opto Biosystems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Opto Biosystems.